Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Laser Tongue Debridement for Oral Malodor" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Laser Tongue Debridement for Oral Malodor for you to read. Along with our medical data and news we also list Laser Tongue Debridement for Oral Malodor Clinical Trials, which are updated daily. BioPortfolio also has a large database of Laser Tongue Debridement for Oral Malodor Companies for you to search.
The US Food and Drug Administration (FDA) has extended its review period for Zogenix’s Fintepla (ZX008, fenfluramine oral solution) to...Read More... The post FDA extends review period of Zogenix’s Fintepla appeared first on Pharmaceutical Technology.
A well-known market intelligence company, Infiniti Research, has announced the completion of its latest success story on market penetration strategy for a medical laser systems client. The engagement helped the client reduce its time to market and enhance overall market share by 37% within a year. This press release features multimedia. View the full release here: https://www.busin
Westwind Integrated Health, a practice providing comprehensive care to Phoenix, AZ from both primary care physicians and dentists, recently hosted an event for Purse Impressions, where over 100 purses were donated. The charity, founded by Patricia Bruscha, a patient of the practice, provides purses, toiletries, and clothing for women graduating from substance abuse rehabilitation centers. PHOENIX ...
In Partnership with the Smiles for Everyone Foundation, Bright Now!® Dental Serves Low-Income Patients Using Grant from Sundt Foundation MESA, Ariz. (PRWEB) February 28, 2020 On Sunday, February 16th, three doctors from Bright Now!® Dental provided underserved communities surrounding Mesa, AZ with the chance to receive free dental care! Dr. Abdullah Ahmad, Dr. Harlean Ahuja, and Dr. Lee...
Drs. Kenneth Nash and Jonathan Nash of Nash Family Dentistry are enhancing smiles in Jackson, MS with porcelain veneers and other cosmetic dentistry treatments as part of their smile makeovers. By utilizing cosmetic dentistry procedures, the doctors are able to enhance the look, feel and function of a patient’s smile. JACKSON, Miss. (PRWEB) February 28, 2020 Respected dentists, Drs. Kenneth Nas...
Sandwich, MA oral surgeon, Dr. William Lane, offers comprehensive full mouth reconstruction, including bone grafting and the placing of dental implants, at his state-of-the-art practice, Lane Oral Surgery. Sandwich, MA (PRWEB) February 28, 2020 Patients who are dissatisfied with the appearance or function of their mouth can receive full mouth reconstruction from distinguished Sandwich, MA oral su...
Medgaus Dental Group offers smile makeovers for those seeking cosmetic dentistry in Monroeville, PA. Smile makeovers are designed to improve the look and function of teeth through multiple dental treatments like teeth whitening and dental implants. MONROEVILLE, Pa. (PRWEB) February 28, 2020 Medgaus Dental Group provides a solution to those suffering from damaged, broken or flawed teeth through co...
US-based medical device firm Ra Medical Systems has enrolled the first patient in clinical study of its DABRA excimer laser system for peripheral vascular stenoses. DABRA is a The post Ra Medical enrols first patient in atherectomy clinical study appeared first on NS Medical Devices.
Ascletis Pharma of Hangzhou has started a China trial of its combination of Ganovo® and Ritonavir as a COVID-19 treatment. The trial, led by Dr. Hongyi Chen, the director of the Ninth Hospital of Nanchang, has already discharged three patients who met China standards for recovery from the infection. Ganovo®, Ascletis' oral protease inhibitor for hepatitis C virus, was approved for China us...
As sector awaits its aducanumab filing with bated breath, Biogen invests again in early stage neuroscience.
SummaryThe global Baby Personal Care Products market will reach xxx Million USD in 2020 with CAGR xx% 20202025. The main contents of the report including:Global market size and forecastRegional market size, production data and export importKey manufacturers profile, products services, sales data of businessGlobal market size by Major EndUseGlobal market size by Major TypeKey manufacturers are in...
Hours before the US FDA confirmed the first drug shortage due to active pharmaceutical ingredient constraints because of the coronavirus...
Government advisory committee gives initial nod to what will become Japan’s most expensive single drug, but reimbursement pricing could come...
This Viewpoint reviews progress and challenges to date in federal and state efforts to transition combination oral contraceptives (COCs) from being prescription only to over-the-counter status in the US.
The U.S. Food and Drug Administration on Thursday approved Biohaven Pharmaceutical Holding Co Ltd's oral pill for relieving pain after the onset of migraine headaches, the drug developer said.
The fast-dissolving tablet will launch in early March. Its list price is not available but based on pricing for Allergan’s...
Appili Therapeutics Inc. (TSXV: APLI) (the “Company” or “Appili”), a biopharmaceutical company focused on anti-infective drug development, today reported its financial and operational results for the third quarter of its fiscal year 2020, ending December 31, 2019. Third quarter and recent operational highlights included: Acquiring ATI-2307, a novel, antifungal candidate from FUJI...
Launch underway for FDA-approved PALFORZIA™, the first treatment for peanut allergy In-licensing of AIMab7195 monoclonal antibody as potential adjunctive treatment with select CODIT™ programs Pro-forma cash and investments of $443 million Webcast and conference call today at 4:30 p.m. ET Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commerciali...
Ophthalmic laser-based medical products provider Iridex has launched second-generation MicroPulse P3 device for the treatment of glaucoma. The company has redesigned the MicroPulse P3 device to deliver better The post Iridex introduces second generation MicroPulse P3 device to treat glaucoma appeared first on NS Medical Devices.
Hong Kong authorities said on Friday they quarantined a pet dog of a coronavirus patient after its nasal and oral samples tested "weak positive" for the virus, though they added they did not yet have evidence that it can be transmitted to pets.
The Aspen Dental office in Glastonbury, CT relocated on Mon., Feb. 24 to make going to the dentist easier. The new location is located at 2955 Main Street. It will accommodate more
Aspen Dental is expanding access to care in the Euless, TX community with a new office opening on Thurs., Feb. 27. The new office, at 2501 Hwy 121 has convenient parking and features many amenities designed to make a
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene and cell therapies, and consumer health products, welcomes the announcement by Blueprint Medicines Corporation that the U.S. Food and Drug Administration (FDA) has approved AYVAKIT™ (avapritinib) for the treatment of adults with unresectable or metastatic g...
A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients.
- Ahead of Rare Disease Day, new support becomes available to the rare community - Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the launch of the Alexion Charitable Foundation to provide further support for the rare disease community and for local communities which the company serves. The key components of the Foundation are the Rare Belonging™ and Local Needs Grants focus areas...